Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Caspi

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
The American Journal of Cardiology|November 15, 1991
Frequency of use of thrombolytic therapy in acute myocardial infarction in IsraelS Behar, E Abinader, A Caspi, et al.
International Journal of Obesity (2005)|May 4, 2017
Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlifeM J A Williams, B J Milne, A Ambler, et al.
Molecular Psychiatry|April 25, 2012
Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal studyI Shalev, T E Moffitt, K Sugden, et al.
British Heart Journal|June 1, 1990
Importance of reciprocal ST segment depression in leads V5 and V6 as an indicator of disease of the left anterior descending coronary artery in acute inferior wall myocardial infarctionB Strasberg, A Pinchas, G I Barbash, et al.
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
The American Journal of Cardiology|March 15, 1991
Effects of nisoldipine on myocardial ischemia during exercise and during daily activityD Tzivoni, S Banai, S Botvin, et al.
The American Journal of Cardiology|April 15, 1993
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)U Goldbourt, S Behar, H Reicher-Reiss, et al.
American Heart Journal|August 1, 1997
Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazemG J Davies, I Kobrin, A Caspi, et al.
American Journal of Therapeutics|July 29, 1999
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil InvestigatorsJ C Somberg, V Yelamanchi, J Molnar, et al.
British Journal of Clinical Pharmacology|December 22, 1999
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiencyR Greenbaum, P Zucchelli, A Caspi, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|November 15, 1991
Frequency of use of thrombolytic therapy in acute myocardial infarction in IsraelS Behar, E Abinader, A Caspi, et al.
International Journal of Obesity (2005)|May 4, 2017
Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlifeM J A Williams, B J Milne, A Ambler, et al.
Molecular Psychiatry|April 25, 2012
Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal studyI Shalev, T E Moffitt, K Sugden, et al.
British Heart Journal|June 1, 1990
Importance of reciprocal ST segment depression in leads V5 and V6 as an indicator of disease of the left anterior descending coronary artery in acute inferior wall myocardial infarctionB Strasberg, A Pinchas, G I Barbash, et al.
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
The American Journal of Cardiology|March 15, 1991
Effects of nisoldipine on myocardial ischemia during exercise and during daily activityD Tzivoni, S Banai, S Botvin, et al.
The American Journal of Cardiology|April 15, 1993
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)U Goldbourt, S Behar, H Reicher-Reiss, et al.
American Heart Journal|August 1, 1997
Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazemG J Davies, I Kobrin, A Caspi, et al.
American Journal of Therapeutics|July 29, 1999
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil InvestigatorsJ C Somberg, V Yelamanchi, J Molnar, et al.
British Journal of Clinical Pharmacology|December 22, 1999
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiencyR Greenbaum, P Zucchelli, A Caspi, et al.
Pageof 17